Stay updated on BCG & ALT-803 Combo in BCG Unresponsive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the BCG & ALT-803 Combo in BCG Unresponsive Bladder Cancer Clinical Trial page.

Latest updates to the BCG & ALT-803 Combo in BCG Unresponsive Bladder Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.2 to v3.8.0; the study record history content remains unchanged.SummaryDifference0.1%

- Check19 days agoChange DetectedA sitewide NIH notice announces a transition to using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI), with both terms appearing during the transition.SummaryDifference0.4%

- Check26 days agoChange DetectedThe ClinicalTrials.gov site footer revision number changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check33 days agoChange DetectedThe site footer release label changes from v3.7.0 to v3.7.1, while the clinical-trial record history remains unchanged.SummaryDifference0.1%

- Check54 days agoChange DetectedA new Revision: v3.7.0 was added to the study's version history and the previous Revision: v3.6.6 was removed, updating the historical record of changes to the study.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision entry, v3.6.6, was added to the study's history and the previous revision v3.6.5 was removed, updating the page's version history. This reflects an update to the page's revision tracking rather than substantive changes to the trial information.SummaryDifference0.1%

Stay in the know with updates to BCG & ALT-803 Combo in BCG Unresponsive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the BCG & ALT-803 Combo in BCG Unresponsive Bladder Cancer Clinical Trial page.